Literature DB >> 23303414

Burst suppression: a more valid marker of postictal central inhibition?

Laura Kranaster1, Peter Plum, Carolin Hoyer, Alexander Sartorius, Heiko Ullrich.   

Abstract

OBJECTIVES: A valid marker to predict seizure adequacy in electroconvulsive therapy (ECT) is still missing. Postictal suppression has been claimed to correlate with the antidepressive effectiveness of an induced seizure. Postictal suppression index (PSI) is derived from a short time span of electroencephalographic recording at seizure termination, and, alternatively, burst suppression (BS) index is defined as the percentage of suppressed epochs within a predefined time period.
METHODS: In a retrospective study including 9 patients with a total of 104 recorded ECT sessions, we compared the influence of variables that are known to alter seizure adequacy like age, stimulation dose, electrode position, and the number of the consecutive ECT sessions on both indices, PSI versus BS index.
RESULTS: For PSI, electrode positioning turned out to be a significant independent variable, with bilateral placement revealing higher PSI. Electroconvulsive therapy session number was significant for BS index, with lower burst suppression in higher ECT session number. In contrast to PSI, BS index turned out to be a significant covariate of seizure duration. Postictal suppression index and BS index did not show linear but a significant rank correlation.
CONCLUSIONS: We report first data about postictal BS index in ECT. As a measure of postictal electrical suppression, BS index appears as robust as PSI. Burst suppression index decreases during an individual ECT course, which presumably reflects the anticonvulsive effect of ECT. Less artifact-prone methods of automatic quantification of electrical suppression could improve precise determination of individual seizure adequacy.

Entities:  

Mesh:

Year:  2013        PMID: 23303414     DOI: 10.1097/YCT.0b013e3182622c0e

Source DB:  PubMed          Journal:  J ECT        ISSN: 1095-0680            Impact factor:   3.635


  6 in total

1.  [Ketamine as anesthetic agent in electroconvulsion therapy].

Authors:  C Janke; J M Bumb; S S Aksay; M Thiel; L Kranaster; A Sartorius
Journal:  Anaesthesist       Date:  2015-05-06       Impact factor: 1.041

2.  A novel Seizure Quality Index based on ictal parameters for optimizing clinical decision making in electroconvulsive therapy. Part 1: development.

Authors:  Laura Kranaster; Suna Su Aksay; Jan Malte Bumb; Carolin Hoyer; Christine Jennen-Steinmetz; Alexander Sartorius
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2018-06-06       Impact factor: 5.270

3.  Overlooking the obvious? Influence of electrolyte concentrations on seizure quality parameters in electroconvulsive therapy.

Authors:  Michael Belz; Isabel Methfessel; Miriam Spang; Matthias Besse; Thorsten Folsche; Caspar Stephani; David Zilles
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2019-07-17       Impact factor: 5.270

Review 4.  How Electroconvulsive Therapy Works?: Understanding the Neurobiological Mechanisms.

Authors:  Amit Singh; Sujita Kumar Kar
Journal:  Clin Psychopharmacol Neurosci       Date:  2017-08-31       Impact factor: 2.582

5.  Leukocyte Gene Expression in Patients with Medication Refractory Depression before and after Treatment with ECT or Isoflurane Anesthesia: A Pilot Study.

Authors:  E Iacob; S C Tadler; K C Light; H R Weeks; K W Smith; A T White; R W Hughen; T A VanHaitsma; L A Bushnell; A R Light
Journal:  Depress Res Treat       Date:  2014-04-13

6.  Isoflurane but Not Halothane Prevents and Reverses Helpless Behavior: A Role for EEG Burst Suppression?

Authors:  P Leon Brown; Panos Zanos; Leiming Wang; Greg I Elmer; Todd D Gould; Paul D Shepard
Journal:  Int J Neuropsychopharmacol       Date:  2018-08-01       Impact factor: 5.176

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.